The Stroop task is a central experimental paradigm used to probe cognitive control by measuring the ability of participants to selectively attend to task-relevant information and inhibit automatic task-irrelevant responses. Research has revealed variability in both experimental manipulations and individual differences. Here, we focus on a particular source of Stroop variability, the reverse-facilitation (RF; faster responses to nonword neutral stimuli than to congruent stimuli), which has recently been suggested as a signature of task conflict. We first review the literature that shows RF variability in the Stroop task, both with regard to experimental manipulations and to individual differences. We suggest that task conflict variability can be understood as resulting from the degree of proactive control that subjects recruit in advance of the Stroop stimulus. When the proactive control is high, task conflict does not arise (or is resolved very quickly), resulting in regular Stroop facilitation. When proactive control is low, task conflict emerges, leading to a slow-down in congruent and incongruent (but not in neutral) trials and thus to Stroop RF. To support this suggestion, we present a computational model of the Stroop task, which includes the resolution of task conflict and its modulation by proactive control. Results show that our model (a) accounts for the variability in Stroop-RF reported in the experimental literature, and (b) solves a challenge to previous Stroop models-their ability to account for reaction time distributional properties. Finally, we discuss theoretical implications to Stroop measures and control deficits observed in some psychopathologies. (PsycINFO Database Record
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1037/rev0000083 | DOI Listing |
BMJ Open
December 2024
Eyu-Ethiopia: Eye Health Research, Training & Service Centre, Bahir Dar, Ethiopia
Introduction: The WHO neglected tropical diseases (NTD) roadmap (2021-2030) proposed a shift in approach to addressing NTDs through accountability for impact, implementing integration across NTDs, mainstreaming in national health systems and ensuring country ownership. However, a major challenge has been the dearth of evidence on how to implement this shift in a resource-limited setting. The objective of this scoping review is to understand the extent and type of evidence on the mainstreaming or integration of programmes and/or interventions against NTDs into the national health system.
View Article and Find Full Text PDFJ Affect Disord
December 2024
Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:
Background: Abnormalities in effort-based decision-making have been consistently reported in major depressive disorder (MDD). Evidence indicates that metabolic factors, such as insulin resistance and dyslipidemia, which are highly prevalent in MDD, are independently associated with reward disturbances. Herein, we investigate the moderating effect of metabolic factors on effort-based decision-making in individuals with MDD.
View Article and Find Full Text PDFNeuroimage
December 2024
Institute of Population Health, University of Liverpool, United Kingdom; Hanse Wissenschaftskolleg, Delmenhorst, Germany. Electronic address:
Recent work has shown rapid microstructural brain changes in response to learning new tasks. These cognitive tasks tend to draw on multiple brain regions connected by white matter (WM) tracts. Therefore, behavioural performance change is likely to be the result of microstructural, functional activation, and connectivity changes in extended neural networks.
View Article and Find Full Text PDFPsychol Res
December 2024
Brain and Cognition, KU Leuven, Leuven, Belgium.
Researchers in numerical cognition have extensively studied the number sense-the innate human ability to extract numerical information from the environment quickly and effortlessly. Much of this research, however, uses abstract stimuli (e.g.
View Article and Find Full Text PDFPsychopharmacology (Berl)
December 2024
Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, 800 E. Leigh St., STE 205, Richmond, VA, 23219-0540, USA.
Rationale α-ET (α-ethyltryptamine), a homolog of the classical hallucinogen α-methyltryptamine, was once prescribed clinically as an antidepressant. Classical psychedelic drugs are currently of interest as potential pharmacotherapy for psychiatric disorders. Objectives Drug discrimination was used to (a) determine if α-ET-like stimulus effects could be engendered by the prototypical phenylalkylamines MDMA ("Ecstasy") or MDA ("Love Drug") and (b) evaluate the α-ET-like stimulus effects of four synthesized aryl-substituted monomethoxy analogs of α-ET (4-OMe-, 5-OMe-, 6-OMe- and 7-OMe-α-ET).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!